We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
-2.68%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$39B
AUM Growth
-$220M
(-0.56%)
Cap. Flow
+$1.59B
Cap. Flow
% of AUM
4.06%
Top 10 Holdings %
Top 10 Hldgs %
16.38%
Holding
2,663
New
306
Increased
844
Reduced
1,189
Closed
301
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$592M |
| 2 |
Tesla
TSLA
|
+$492M |
| 3 |
Amazon
AMZN
|
+$474M |
| 4 |
Advanced Micro Devices
AMD
|
+$410M |
| 5 |
Qualcomm
QCOM
|
+$358M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$393M |
| 2 |
Union Pacific
UNP
|
+$363M |
| 3 |
Walmart Inc
WMT
|
+$239M |
| 4 |
Citigroup
C
|
+$192M |
| 5 |
ConocoPhillips
COP
|
+$172M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.84% |
| 2 | Healthcare | 15.27% |
| 3 | Consumer Discretionary | 13.96% |
| 4 | Industrials | 10.47% |
| 5 | Financials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
OP Bancorp
OPBK
$236M
| $170K | ﹤0.01% |
18,600
| – | – |
|
|
FSR
2127
DELISTED
Fisker Inc.
FSR
| $170K | ﹤0.01% |
26,500
-160,000
| -86% | -$973K |
|
2128
Lipocine
LPCN
$17.1M
| $170K | ﹤0.01% |
+56,922
| New | +$239K |
|
|
EMKR
2129
DELISTED
Emcore Corp
EMKR
| $169K | ﹤0.01% |
35,563
-7,960
| -18% | -$51.8K |
|
|
BFIN
2130
DELISTED
BankFinancial
BFIN
| $169K | ﹤0.01% |
19,585
| – | – |
|
|
FONR
2131
DELISTED
Fonar
FONR
| $168K | ﹤0.01% |
10,900
-400
| -4% | -$6.61K |
|
2132
Aurora
AUR
$12.3B
| $166K | ﹤0.01% |
70,600
+22,300
| +46% | +$69.1K |
|
|
CRON
2133
Cronos Group
CRON
$1.06B
| $165K | ﹤0.01% |
82,700
+18,500
| +29% | +$36.2K |
|
2134
Sana Biotechnology
SANA
$899M
| $165K | ﹤0.01% |
42,700
-17,800
| -29% | -$95.7K |
|
2135
Bioventus
BVS
$912M
| $163K | ﹤0.01% |
49,532
+27,500
| +125% | +$96.5K |
|
2136
Oric Pharmaceuticals
ORIC
$1.2B
| $160K | ﹤0.01% |
26,500
-52,500
| -66% | -$430K |
|
2137
Pyxis Oncology
PYXS
$192M
| $160K | ﹤0.01% |
80,500
+55,700
| +225% | +$129K |
|
|
AKU
2138
DELISTED
Akumin Inc
AKU
| $159K | ﹤0.01% |
1,092,746
+207,000
| +23% | +$33.2K |
|
|
MRNS
2139
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $159K | ﹤0.01% |
19,725
-54,300
| -73% | -$452K |
|
2140
Passage Bio
PASG
$14.6M
| $158K | ﹤0.01% |
12,010
-375
| -3% | -$6.16K |
|
2141
Kodak
KODK
$817M
| $157K | ﹤0.01% |
37,200
+200
| +0.5% | +$979 |
|
|
ORC
2142
Orchid Island Capital
ORC
$1.32B
| $153K | ﹤0.01% |
+18,000
| New | +$177K |
|
2143
Pagaya Technologies
PGY
$1.4B
| $153K | ﹤0.01% |
+8,075
| New | +$196K |
|
2144
Cerus
CERS
$581M
| $153K | ﹤0.01% |
+94,400
| New | +$196K |
|
|
EQRX
2145
DELISTED
EQRx, Inc. Common Stock
EQRX
| $152K | ﹤0.01% |
68,300
+34,500
| +102% | +$73.9K |
|
2146
Nurix Therapeutics
NRIX
$2.49B
| $151K | ﹤0.01% |
19,200
+4,000
| +26% | +$36.5K |
|
2147
Precigen
PGEN
$1.98B
| $151K | ﹤0.01% |
106,200
-50,800
| -32% | -$72K |
|
|
KNTE
2148
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $150K | ﹤0.01% |
107,000
+89,600
| +515% | +$215K |
|
2149
Personalis
PSNL
$1.28B
| $150K | ﹤0.01% |
123,600
-39,500
| -24% | -$70.6K |
|
|
SJT
2150
San Juan Basin Royalty Trust
SJT
$120M
| $149K | ﹤0.01% |
21,500
+1,600
| +8% | +$11.5K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q3 2023 Portfolio in Review
As of Q3 2023, Two Sigma Advisers held 2,663 positions worth $39B, down 0.56% from $39.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Two Sigma Advisers deployed $1.59B of net new capital in Q3 2023, opening 306 new positions and adding to 844 existing holdings. Its largest new stake was Advanced Micro Devices: 3,777,240 shares worth $388M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Charles Schwab, an estimated $393M trimmed.
- Two Sigma Advisers's largest Q3 2023 buy was Advanced Micro Devices: 3,777,240 shares worth $388M.
- Two Sigma Advisers added most to Microsoft in Q3 2023, an estimated $592M increase.
- Two Sigma Advisers's biggest Q3 2023 reduction was Charles Schwab, cutting an estimated $393M.
- Two Sigma Advisers fully exited Uber in Q3 2023, selling an estimated $109M.
- Two Sigma Advisers's ten largest holdings make up 16% of its $39B portfolio in Q3 2023.
- Two Sigma Advisers opened 306 new positions and closed 301 in Q3 2023.
- Two Sigma Advisers's portfolio value fell 0.56% quarter-over-quarter to $39B.
Based on Two Sigma Advisers's 13F filing for Q3 2023, filed 14 Nov 2023.